Candidiasis News and Research

RSS
Candiadiasis, or Thrush, is a fungal infection caused by a group of yeast. There is a score of Candida species, the commonest of which is Candida albicans. They normally inhabit the surfaces and mucus linings of the human body. This includes mouth, vaginal cavity gastrointestinal tract etc.
Alder bark may be great source of anti-aging and anti-disease natural antioxidants

Alder bark may be great source of anti-aging and anti-disease natural antioxidants

Researchers create new material with antifungal and antitumor properties

Researchers create new material with antifungal and antitumor properties

New compound could take on lethal fungal, bacterial infections in immunocompromised people

New compound could take on lethal fungal, bacterial infections in immunocompromised people

Brazilian plant extract fights Candidiasis

Brazilian plant extract fights Candidiasis

ATS publishes clinical guideline on laboratory diagnosis of fungal infections

ATS publishes clinical guideline on laboratory diagnosis of fungal infections

Researchers find presence of Aire gene in lymph nodes

Researchers find presence of Aire gene in lymph nodes

Researchers isolate compound that kills drug-resistant fungi from ant microbiota

Researchers isolate compound that kills drug-resistant fungi from ant microbiota

Study develops simple, new treatment to fight Candida Albicans fungus

Study develops simple, new treatment to fight Candida Albicans fungus

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

FDA approves first generic version of commonly prescribed asthma inhaler

FDA approves first generic version of commonly prescribed asthma inhaler

Cloned antibodies show potential to treat, diagnose life-threatening fungal infections

Cloned antibodies show potential to treat, diagnose life-threatening fungal infections

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with RVVC

Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with RVVC

Dectin-1 pathway could be important new target for treatment of candidiasis, study shows

Dectin-1 pathway could be important new target for treatment of candidiasis, study shows

Scientists sequence and analyze genomes of Candida albicans

Scientists sequence and analyze genomes of Candida albicans

NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees

NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees

Could a rare, deadly ‘superbug’ fungus be gaining a foothold?

Could a rare, deadly ‘superbug’ fungus be gaining a foothold?

New genetic analysis of candidiasis reveals surprising fungal sex secrets

New genetic analysis of candidiasis reveals surprising fungal sex secrets

New testing regime could speed up diagnosis and treatment of SCID in infants

New testing regime could speed up diagnosis and treatment of SCID in infants